[Immunodeficiency induced by immunosuppressive agents].
Ohashi
H
H
Internal Medicine III, Hamamatsu University School of Medicine.
Ohno
R
R
D001379:Azathioprine / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011239:Prednisolone / Q000009:adverse effects; D011379:Prognosis; D016559:Tacrolimus / Q000009:adverse effects
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus; D008727:Methotrexate